Source: International Journal of Gynecological Cancer. Unidades: SVOI, FMRP
Subjects: BIOMARCADORES, ESTUDOS DE COORTES, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, FATORES DE RISCO, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSAHKIAN, Juliana A. et al. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, v. 28, n. 3, p. 459-465, 2018Tradução . . Disponível em: https://doi.org/10.1097/igc.0000000000001193. Acesso em: 01 out. 2024.APA
Josahkian, J. A., Saggioro, F. P., Vidotto, T., Ventura, H. T., Reis, F. J. C. dos, Sousa, C. B. de, et al. (2018). Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, 28( 3), 459-465. doi:10.1097/igc.0000000000001193NLM
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 out. 01 ] Available from: https://doi.org/10.1097/igc.0000000000001193Vancouver
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 out. 01 ] Available from: https://doi.org/10.1097/igc.0000000000001193
